Toronto Dominion Bank
BIO icon

Toronto Dominion Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Toronto Dominion Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Sell
1,436
-375
-21% -$108K ﹤0.01% 1476
2025
Q4 		$548K Hold
1,811
– – ﹤0.01% 1346
2025
Q3 		$489K Sell
1,811
-150
-8% -$40.8K ﹤0.01% 1281
2025
Q2 		$474K Sell
1,961
-2,781
-59% -$657K ﹤0.01% 1191
2025
Q1 		$1.15M Buy
4,742
+690
+17% +$208K ﹤0.01% 1051
2024
Q4 		$1.33M Buy
4,052
+346
+9% +$117K ﹤0.01% 1008
2024
Q3 		$1.24M Sell
3,706
-2,864
-44% -$910K ﹤0.01% 830
2024
Q2 		$1.79M Sell
6,570
-6,269
-49% -$1.82M ﹤0.01% 806
2024
Q1 		$4.44M Buy
12,839
+228
+2% +$75K 0.01% 659
2023
Q4 		$4.07M Buy
12,611
+634
+5% +$199K 0.01% 728
2023
Q3 		$4.29M Sell
11,977
-483
-4% -$186K 0.01% 719
2023
Q2 		$4.72M Buy
12,460
+449
+4% +$183K 0.01% 717
2023
Q1 		$5.75M Buy
12,011
+94
+0.8% +$44K 0.01% 648
2022
Q4 		$5.01M Buy
11,917
+1,830
+18% +$739K 0.01% 684
2022
Q3 		$4.21M Sell
10,087
-1,669
-14% -$832K 0.01% 709
2022
Q2 		$5.82M Sell
11,756
-1,541
-12% -$803K 0.01% 542
2022
Q1 		$7.49M Buy
13,297
+2,132
+19% +$1.29M 0.01% 526
2021
Q4 		$8.44M Sell
11,165
-48,232
-81% -$36.1M 0.01% 545
2021
Q3 		$44.3M Buy
59,397
+25,538
+75% +$19.1M 0.07% 162
2021
Q2 		$21.8M Buy
33,859
+22,939
+210% +$14M 0.03% 303
2021
Q1 		$6.24M Sell
10,920
-2,064
-16% -$1.22M 0.01% 543
2020
Q4 		$7.57M Buy
12,984
+805
+7% +$458K 0.01% 506
2020
Q3 		$6.28M Sell
12,179
-2,003
-14% -$1.01M 0.02% 482
2020
Q2 		$6.4M Buy
14,182
+11,131
+365% +$4.91M 0.02% 540
2020
Q1 		$1.07M Sell
3,051
-843
-22% -$310K ﹤0.01% 746
2019
Q4 		$1.44M Buy
3,894
+3,885
+43,167% +$1.37M ﹤0.01% 824
2019
Q3 		$3K Sell
9
-9
-50% -$2.94K ﹤0.01% 1353
2019
Q2 		$3K Buy
18
+8
+80% +$2.4K ﹤0.01% 1313
2019
Q1 		$3K Buy
+10
New +$2.7K ﹤0.01% 1407

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Toronto Dominion Bank's BIO Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Bio-Rad Laboratories Class A (BIO) stake by 21% in Q1 2026, selling an estimated $108K and leaving 1,436 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Toronto Dominion Bank first reported a position in BIO in Q1 2019 and has held it in 29 quarters since. The position peaked at $44.3M in Q3 2021. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Toronto Dominion Bank held 1,436 shares of Bio-Rad Laboratories Class A worth $401K as of Q1 2026.
  • Toronto Dominion Bank sold 375 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $108K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1476 holding.
  • Toronto Dominion Bank first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and has held it in 29 quarters since.
  • Toronto Dominion Bank's Bio-Rad Laboratories Class A position peaked at $44.3M in Q3 2021.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.